Prevalence, Treatment, and Control of Diagnosed Diabetes in the U.S. National Health and Nutrition Examination Survey 1999–2004
Abstract
Purpose This study aimed to examine the trends in prevalence, treatment, and control of diagnosed diabetes in United States adults 20 years of age or older.Methods Data from the National Health and Nutrition Examination Survey 1999-2004 were used. Glycemic, blood pressure, and total cholesterol target levels were defined as having glycosylated hemoglobin <7.0%, blood pressure <130/80 mm Hg, and total cholesterol <200 mg/dL, respectively.Results The prevalence of diagnosed diabetes was 7.8% in 2003-2004 and increased significantly in people aged 40-59 years, women, non-Hispanic whites, and obese people in the period 1999-2004. Although there was no significant change in the pattern of antidiabetic treatment, the age-adjusted percentage of people with diagnosed diabetes achieving glycemic and blood pressure target levels increased from 35.8% to 57.1% (p = 0.002) and from 35.7% to 48.3% (p = 0.04), respectively. However, there were only insignificant increases in percentages of those persons achieving total cholesterol target level (from 48.8% to 50.4%) and those achieving all 3 target levels (from 7.5% to 13.2%).Conclusions In 1999-2004, the prevalence of diagnosed diabetes increased significantly in some subgroups of the population. However, the increases in percentages of people with diabetes achieving glycemic and blood pressure targets are encouraging, although there is room for improvement.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Many racial/ethnic minority groups, particularly Blacks/African-Americans and Hispanics-Latinos, are at greater risk of obesity, heart disease, diabetes, and cardiovascular events.
“In particular many racial/ethnic minority groups (particularly Blacks/African-Americans and Hispanics-Latinos) are at greater risk of obesity, heart disease, diabetes, and cardiovascular events (204, 206, 207).”
From Sleep: important considerations for the prevention of cardiovascular disease (2016) · cites this paper as [207]
African-Americans and Mexican-Americans are at greater risk of developing diabetes compared to non-Hispanic whites.
“African-Americans and Mexican-Americans are at greater risk of developing diabetes compared to non-Hispanic whites [3]”
From Association between sleep deficiency and cardiometabolic disease: implications for health disparities (2016) · cites this paper as [3]
Racial/ethnic and socioeconomic disparities exist in cardiometabolic diseases, with minority populations such as African Americans and Hispanics and those of lower socioeconomic status experiencing a greater burden.
“Unfortunately, racial/ethnic and socioeconomic disparities in these diseases exist such that minority populations, such as African Americans and Hispanics, and those of lower socioeconomic status, experience a greater burden.”
From Association between sleep deficiency and cardiometabolic disease: implications for health disparities (2016) · cites this paper as [3]
Cites
1 retracted
Thiazolidinediones for the treatment of type 2 diabetes
Elte, J. W. F., & Blickle, J. (2007) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2006.09.007 · Cited by 77 · see citing works
RetractedGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667 · see citing works
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271 · see citing works
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000 · see citing works
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 4,803 · see citing works
Economic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147 · see citing works
Turner, R. D., & Holman, R. R. (1998) · Cited by 1,973 · see citing works
Standards of Medical Care in Diabetes–2006
American Diabetes Association (2006) · Diabetes Care · doi:10.2337/diacare.29.s1.06.s4 · Cited by 1,884 · see citing works
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839 · see citing works
Human blood pressure determination by sphygmomanometry.
Perloff, D., Grim, C. M., Flack, J. M., Frohlich, E. D., Hill, M. D., McDonald, M., & Morgenstern, B. Z. (1993) · Circulation · doi:10.1161/01.cir.88.5.2460 · Cited by 1,592 · see citing works
Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
Ong, K. L., Cheung, B. M. Y., Man, Y. B., Lau, C. P., & Lam, K. S. L. (2007) · Hypertension · doi:10.1161/01.hyp.0000252676.46043.18 · Cited by 1,395 · see citing works
Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes
Saydah, S. H. (2004) · JAMA · doi:10.1001/jama.291.3.335 · Cited by 1,357 · see citing works
Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population
Cowie, C. C., Rust, K. F., Byrd-Holt, D. D., Eberhardt, M. S., Flegal, K. M., Engelgau, M. M., Saydah, S. H., Williams, D. E., Geiss, L. S., & Gregg, E. W. (2006) · Diabetes Care · doi:10.2337/dc06-0062 · Cited by 1,210 · see citing works
Nowy rok, stare problemy, ale i nowe możliwości
Czupryniak, L. (2014) · Via Medica Journals · Cited by 1,192 · see citing works
Standards of Medical Care in Diabetes–2006
Tseng, K. H. (2006) · Diabetes Care · doi:10.2337/dc06-0805 · Cited by 1,099 · see citing works
Glycemic Control From 1988 to 2000 Among U.S. Adults Diagnosed With Type 2 Diabetes
Koro, C. E., Bowlin, S. J., Bourgeois, N., & Fedder, D. O. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.17 · Cited by 648 · see citing works
Racial and ethnic differences in glycemic control of adults with type 2 diabetes.
Harris, M. I., Eastman, R. C., Cowie, C. C., Flegal, K. M., & Eberhardt, M. S. (1999) · Diabetes Care · doi:10.2337/diacare.22.3.403 · Cited by 643 · see citing works
Age Adjustment Using the 2000 Projected U.S. Population
Klein, R. J., & Schoenborn, C. A. (2001) · PsycEXTRA Dataset · doi:10.1037/e583772012-001 · Cited by 580 · see citing works
Purnell, J. Q., Hokanson, J. E., Marcovina, S. M., Steffes, M. W., Cleary, P. A., & Brunzell, J. D. (1998) · JAMA · doi:10.1001/jama.280.2.140 · Cited by 469 · see citing works
Resnick, H. E., Foster, G. L., Bardsley, J. K., & Ratner, R. E. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-1254 · Cited by 428 · see citing works
Weight Gain Associated With Intensive Therapy in the Diabetes Control and Complications Trial
The DCCT Research Group (1988) · Diabetes Care · doi:10.2337/diacare.11.7.567 · Cited by 345 · see citing works
Changes in Age at Diagnosis of Type 2 Diabetes Mellitus in the United States, 1988 to 2000
Koopman, R. J. (2005) · The Annals of Family Medicine · doi:10.1370/afm.214 · Cited by 291 · see citing works
Prevalence of Diabetes and Impaired Fasting Glucose in Adults—United States, 1999-2000
Torpy, J. M., Lynm, C., & Glass, R. M. (2003) · JAMA · doi:10.1001/jama.290.13.1702 · Cited by 227 · see citing works
Hyperglycemic Crises in Patients With Diabetes Mellitus
American Diabetes Association (2001) · Diabetes Care · doi:10.2337/diacare.24.1.154 · Cited by 173 · see citing works
Antihypertensive Medication Use Among US Adults With Hypertension
Gu, Q., Paulose‐Ram, R., Dillon, C. F., & Burt, V. L. (2006) · Circulation · doi:10.1161/circulationaha.105.542290 · Cited by 149 · see citing works
Standards of Medical Care for Patients With Diabetes Mellitus
American Diabetes Association (1998) · Diabetes Care · doi:10.2337/diacare.21.1.s23 · Cited by 111 · see citing works
Cheung, B. M. Y., Ong, K. L., Man, Y. B., Lam, K. S. L., & Lau, C. (2006) · Journal of Clinical Hypertension · doi:10.1111/j.1524-6175.2006.04895.x · Cited by 88 · see citing works
Anti‐diabetic effect of blockade of the renin‐angiotensin system
Ando, K., & Fujita, T. (2005) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00526.x · Cited by 27 · see citing works
An update on Americans' access to prescription drugs.
Reed, M. C. (2005) · PubMed · Cited by 18 · see citing works
Flagged first, then by citations
2 of the 35 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650 · see citing works
Mosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143 · see citing works
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306 · see citing works
Effectiveness-Based Guidelines for the Prevention of Cardiovascular Disease in Women—2011 Update
Mosca, L. J., Benjamin, E. J., Berra, K. A., Bezanson, J. L., Dolor, R. J., Lloyd‐Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.005 · Cited by 783 · see citing works
Goldstein, L. B., Bushnell, C., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · Cited by 745 · see citing works
Sleep disparity, race/ethnicity, and socioeconomic position
Grandner, M. A., Williams, N. J., Knutson, K. L., Roberts, D., & Jean-Louis, G. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2015.01.020 · Cited by 481 · see citing works
Glycemic control and complications in type 2 diabetes mellitus
Stolar, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.004 · Cited by 356 · see citing works
Diabetes Prevalence and Therapeutic Target Achievement in the United States, 1999 to 2006
Cheung, B. M. Y., Ong, K. L., Cherny, S. S., Sham, P. C., Tso, A. W. K., & Lam, K. S. L. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.047 · Cited by 348 · see citing works
McWilliams, J. M., Meara, E., Zaslavsky, A. M., & Ayanian, J. Z. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-8-200904210-00005 · Cited by 315 · see citing works
Risk Factors for Heart Failure: A Population-Based Case-Control Study
Dunlay, S. M., Weston, S. A., Jacobsen, S. J., & Roger, V. L. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.04.022 · Cited by 302 · see citing works
Heise, T., Seewaldt-Becker, E., Macha, S., Hantel, S., Pinnetti, S., SEMAN, L. J., & Woerle, H. J. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12073 · Cited by 273 · see citing works
Patient adherence to medication requirements for therapy of type 2 diabetes
Bailey, C. J., & Kodack, M. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02544.x · Cited by 255 · see citing works
The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes
Currie, C. J., Peyrot, M. F., Morgan, C. L., Poole, C., Jenkins‐Jones, S., Rubin, R. R., Burton, C. M., & Evans, M. (2012) · Diabetes Care · doi:10.2337/dc11-1277 · Cited by 252 · see citing works
Potential of Albiglutide, a Long-Acting GLP-1 Receptor Agonist, in Type 2 Diabetes
Rosenstock, J., Reusch, J. E. B., Bush, M., Yang, F., Stewart, M. W., & for the Albiglutide Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0366 · Cited by 237 · see citing works
Åhrén, B., JOHNSON, S. L., Stewart, M. W., Cirkel, D. T., Yang, F., Perry, C., & Feinglos, M. N. (2014) · Diabetes Care · doi:10.2337/dc14-0024 · Cited by 228 · see citing works
Wyman, J. F., Burgio, K. L., & Newman, D. K. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02078.x · Cited by 224 · see citing works
Pharmacology of Dipeptidyl Peptidase-4 Inhibitors
Baetta, R., & Corsini, A. (2011) · Drugs · doi:10.2165/11591400-000000000-00000 · Cited by 211 · see citing works
Brehm, B. J., Lattin, B. L., Summer, S. S., Boback, J. A., Gilchrist, G. M., Jandacek, R. J., & D’Alessio, D. A. (2009) · Diabetes Care · doi:10.2337/dc08-0687 · Cited by 196 · see citing works
Glycaemic control in type 2 diabetes: Targets and new therapies
Tahrani, A. A., Piya, M. K., Kennedy, A., & Barnett, A. H. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.11.001 · Cited by 189 · see citing works
Unraveling the Science of Incretin Biology
Nauck, M. A. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.03.012 · Cited by 168 · see citing works
Sleep: important considerations for the prevention of cardiovascular disease
Grandner, M. A., Alfonso-Miller, P., Fernandez-Mendoza, J., Shetty, S., Shenoy, S., & Combs, D. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000324 · Cited by 166 · see citing works
Alzaheb, R., & Altemani, A. (2018) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s156214 · Cited by 160 · see citing works
Adverse effects and safety of SGLT-2 inhibitors
Halimi, S., & Vergès, B. L. (2014) · Diabetes & Metabolism · doi:10.1016/s1262-3636(14)72693-x · Cited by 160 · see citing works
Burrows, N. R., Li, Y., & Geiss, L. S. (2009) · Diabetes Care · doi:10.2337/dc09-0343 · Cited by 157 · see citing works
Ratner, R. E., Rosenstock, J., Boka, G., & on behalf of the DRI6012 Study Investigators (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03020.x · Cited by 155 · see citing works
Sodium-Glucose Co-Transport Inhibitors
Neumiller, J. J., White, J. R., & Campbell, R. K. (2010) · Drugs · doi:10.2165/11318680-000000000-00000 · Cited by 154 · see citing works
Why are we failing to implement effective therapies in cardiovascular disease?
Nieuwlaat, R., Schwalm, J.-D., Khatib, R., & Yusuf, S. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs481 · Cited by 152 · see citing works
Dipeptidyl Peptidase‐4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Neumiller, J. J., Wood, L. D., & Campbell, R. K. (2010) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.30.5.463 · Cited by 149 · see citing works
Fujita, Y., & Inagaki, N. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12214 · Cited by 148 · see citing works
Alonso, Á., Mosley, T. H., Gottesman, R. F., Catellier, D., Sharrett, A. R., & Coresh, J. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.176818 · Cited by 147 · see citing works
Neumiller, J. J. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.09078 · Cited by 144 · see citing works
Kurosaki, E., & Ogasawara, H. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.04.003 · Cited by 136 · see citing works
Colesevelam lowers glucose and lipid levels in type 2 diabetes: The clinical evidence
Fonseca, V. A., Handelsman, Y., & Staels, B. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01181.x · Cited by 130 · see citing works
Megatrials in type 2 diabetes. From excitement to frustration?
Prato, S. D. (2009) · Diabetologia · doi:10.1007/s00125-009-1352-5 · Cited by 130 · see citing works
Evaluation of a hypertension medication therapy management program in patients with diabetes
Planas, L. G., Crosby, K. M., Mitchell, K. D., & Farmer, K. C. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.08164 · Cited by 127 · see citing works
Morrison, F. J. R., Shubina, M., & Turchin, A. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.400 · Cited by 119 · see citing works
Rangaraj, V. R., & Knutson, K. L. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2015.02.535 · Cited by 120 · see citing works
Zinman, B., Schmidt, W. E., Moses, A. C., Lund, N., & Gough, S. C. L. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01493.x · Cited by 119 · see citing works
Lou, P., Qin, Y., Zhang, P., Chen, P., Zhang, L., Chang, G., Li, T., Qiao, C., & Zhang, N. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.060 · Cited by 117 · see citing works
Menke, A., Rust, K., FRADKIN, J. E., Cheng, Y. J., & Cowie, C. C. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0286 · Cited by 115 · see citing works
Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents
Lee, Y., Lingvay, I., Szczepaniak, L. S., Ravazzola, M., Orci, L., & Unger, R. H. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.245 · Cited by 115 · see citing works
Knutson, K. L., Wu, D., Patel, S. R., Loredo, J. S., Redline, S. S., Cai, J., Gallo, L. C., Mossavar‐Rahmani, Y., Ramos, A. R., Teng, Y., et al. (2017) · SLEEP · doi:10.1093/sleep/zsx014 · Cited by 113 · see citing works
Giaconi, J. A., Yu, F., Stone, K. L., Pedula, K. L., Ensrud, K. E., Cauley, J. A., Hochberg, M. C., & Coleman, A. L. (2012) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2012.03.048 · Cited by 109 · see citing works
Adeniyi, O. V., Yogeswaran, P., Longo‐Mbenza, B., & Goon, D. T. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150033 · Cited by 108 · see citing works
Are Individuals With Diabetes Seeing Better?
Klein, R., & Klein, R. (2010) · Diabetes · doi:10.2337/db09-1904 · Cited by 106 · see citing works
Plosker, G. L. (2012) · Drugs · doi:10.2165/11209910-000000000-00000 · Cited by 98 · see citing works
Clarifying the Role of Incretin-Based Therapies in the Treatment of Type 2 Diabetes Mellitus
Campbell, R. K. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.04.015 · Cited by 92 · see citing works
Prevalence, awareness and treatment of type 2 diabetes mellitus in Switzerland: the CoLaus study
Kaiser, A. V., Vollenweider, P., Waeber, G., & Marques-Vidal, P. M. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03422.x · Cited by 92 · see citing works
The Hypertension–Diabetes Continuum
Cheung, B. M. Y. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181d26430 · Cited by 88 · see citing works
Chen, X., He, Z., Zhou, Z., Yang, T., Zhang, X., Yang, Y., Duan, W., & Zhou, S. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12455 · Cited by 87 · see citing works
Pi-Sunyer, X. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.09.2056 · Cited by 86 · see citing works
Rees, C. A., Karter, A. J., & Young, B. A. (2010) · The Diabetes Educator · doi:10.1177/0145721710364419 · Cited by 83 · see citing works
Sims, M., Diez Roux, A. V., Boykin, S., Sarpong, D., Gebreab, S. Y., Wyatt, S. B., Hickson, D., Payton, M., Ekunwe, L., & Taylor, H. A. (2011) · Annals of Epidemiology · doi:10.1016/j.annepidem.2011.05.006 · Cited by 81 · see citing works
“Diabetes control for men and women in our sample was lower than the national total for African Americans in the US as of 2004 (3) (35.”
BackgroundFord, E. S. (2011) · Journal of Diabetes · doi:10.1111/j.1753-0407.2011.00148.x · Cited by 79 · see citing works
Wang, C., Yu, Y., Zhang, X., Li, Y., Chang-gui, K., Li, B., Tao, Y., Zhen, Q., He, H., Kanu, J. S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103594 · Cited by 74 · see citing works
Abbott, S. M., Weng, J. F., Reid, K. J., Daviglus, M. L., Gallo, L. C., Loredo, J. S., Nyenhuis, S. M., Ramos, A. R., Shah, N. A., Sotres‐Alvarez, D., et al. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.09.018 · Cited by 74 · see citing works
Prevalence of diabetes in Northern African countries: the case of Tunisia
Romdhane, H. B., Ali, S. B., Aissi, W., Traissac, P., Skhiri, H. A., Bougatef, S., Maire, B., Delpeuch, F., & Achour, N. (2014) · BMC Public Health · doi:10.1186/1471-2458-14-86 · Cited by 72 · see citing works
Joubert, M., & Reznik, Y. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.12.010 · Cited by 70 · see citing works
Progress Toward Universal Health Coverage
Rahman, M. M., Karan, A., Rahman, M. S., Parsons, A. J. Q., Abe, S. K., Bilano, V. L. F., Awan, R. P., Gilmour, S., & Shibuya, K. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.3133 · Cited by 70 · see citing works
Efficacy of the Smartphone-Based Glucose Management Application Stratified by User Satisfaction
Kim, H.-S., Choi, W., Baek, E. K., Kim, Y. A., Yang, S. J., Choi, I. Y., Yoon, K.-H., & Cho, J.-H. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.3.204 · Cited by 68 · see citing works
Dailey, G. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.04.025 · Cited by 66 · see citing works
Trends of ABC control 2006–2011: A National Survey of Diabetes Health Promotion Institutes in Taiwan
Yu, N.-C., Su, H.-Y., Chiou, S.-T., Yeh, M. C., Yeh, S.-W., Tzeng, M.-S., & Sheu, W. H. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.11.018 · Cited by 66 · see citing works
Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time?
Zinman, B. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.003 · Cited by 65 · see citing works
Estoppey, D., Paccaud, F. M., Vollenweider, P., & Marques-Vidal, P. M. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-114 · Cited by 64 · see citing works
Role of the incretin pathway in the pathogenesis of type 2 diabetes mellitus
Kennedy, L., & Freeman, J. S. (2009) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.76.s5.03 · Cited by 62 · see citing works
Mexico-California Diabetes collaborative group, Barquera, S., Schillinger, D., Aguilar-Salinas, C. A., Schenker, M. B., Rodríguez, L. A., Hernández-Alcaraz, C., & Sepúlveda-Amor, J. (2018) · Globalization and Health · doi:10.1186/s12992-018-0390-5 · Cited by 62 · see citing works
Unraveling the Science of Incretin Biology
Nauck, M. A. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2009.05.012 · Cited by 61 · see citing works
Lee, H. J., Kim, H. C., Vı́tek, L., & Nam, C. M. (2010) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.56.13 · Cited by 61 · see citing works
Defining and Achieving Treatment Success in Patients With Type 2 Diabetes Mellitus
STOLAR, M. W. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0471 · Cited by 59 · see citing works
Kuznik, A., & Mardekian, J. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-31 · Cited by 59 · see citing works
Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications
Beisswenger, P. J. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130275 · Cited by 59 · see citing works
Trends in the prevalence and management of diabetes in Korea: 2007-2017
Shin, J.-Y. (2019) · Epidemiology and Health · doi:10.4178/epih.e2019029 · Cited by 60 · see citing works
Morrison, F. J. R., Shubina, M., & Turchin, A. (2012) · Diabetes Care · doi:10.2337/dc11-1635 · Cited by 57 · see citing works
Are current clinical trials in diabetes addressing important issues in diabetes care?
Lakey, W. C., Barnard, K., Batch, B. C., Chiswell, K., Tasneem, A., & Green, J. B. (2013) · Diabetologia · doi:10.1007/s00125-013-2890-4 · Cited by 55 · see citing works
Poucher, S. M., Cheetham, S. C., Francis, J., Zinker, B. A., Kirby, M., & Vickers, S. P. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01619.x · Cited by 51 · see citing works
The Epidemiology of Diabetic Retinopathy
Klein, R. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-563-3_3 · Cited by 51 · see citing works
Vega‐López, S., Chavez, A., Farr, K. J., & Ainsworth, B. E. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-29 · Cited by 50 · see citing works
Current Concepts in Diabetic Retinopathy
Song, S. J., & Wong, T. Y. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.6.416 · Cited by 47 · see citing works
Fritz, J., Phillips, A., Hunt, L., Imam, A., Reid, K., Perreira, K., Mossavar-Rahmani, Y., Daviglus, M., Sotres-Alvarez, D., Zee, P., et al. (2020) · Sleep · doi:10.1093/sleep/zsaa218 · Cited by 36 · see citing works
Frier, B. M., Russell-Jones, D. L., & Heise, T. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12106 · Cited by 46 · see citing works
Predictors of parent–child relationships that support physical activity in Mexican–American families
de la Haye, K., de Heer, H. ‘., Wilkinson, A. V., & Koehly, L. M. (2012) · Journal of Behavioral Medicine · doi:10.1007/s10865-012-9471-8 · Cited by 45 · see citing works
Saxagliptin: A dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitus
Neumiller, J. J., & Campbell, R. K. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090555 · Cited by 42 · see citing works
Changing the Treatment Paradigm for Type 2 Diabetes
Prato, S. D., Penno, G., & Miccoli, R. (2009) · Diabetes Care · doi:10.2337/dc09-s314 · Cited by 42 · see citing works
Coadjuvants in the Diabetic Complications: Nutraceuticals and Drugs with Pleiotropic Effects
Pereira, T. D. M. C., Pimenta, F. S., Porto, M. L., Baldo, M. P., Campagnaro, B. P., Gava, A. L., Meyrelles, S. S., & Vasquez, E. C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081273 · Cited by 43 · see citing works
Excess Frequent Insufficient Sleep in American Indians/Alaska Natives
Chapman, D. P., Croft, J. B., Liu, Y., Perry, G. S., Presley-Cantrell, L. R., & Ford, E. S. (2013) · Journal of Environmental and Public Health · doi:10.1155/2013/259645 · Cited by 43 · see citing works
Owolabi, E. O., Goon, D. T., Adeniyi, O. V., & Seekoe, E. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014349 · Cited by 42 · see citing works
Borrell, L., Crawford, N., Dallo, F. J., & Baquero, M. (2009) · Public health reports (1974) · doi:10.1177/003335490912400512 · Cited by 44 · see citing works
Dapagliflozin: more than just another oral glucose-lowering agent?
Katsiki, N., Παπάνας, Ν., & Mikhailidis, D. P. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.539558 · Cited by 39 · see citing works
Cardiovascular safety and diabetes drug development
Drucker, D. J., & Goldfine, A. B. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62299-4 · Cited by 38 · see citing works
Abubakari, A., Jones, M. C., Lauder, W., Kirk, A. F., Devendra, Anderson, J. V., & Naderali, E. K. (2013) · International Journal of General Medicine · doi:10.2147/ijgm.s46649 · Cited by 38 · see citing works
Diabetes after Kidney Donation
Ibrahim, H. N., Kukla, A., Cordner, G., Bailey, R., Gillingham, K. J., & Matas, A. J. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02944.x · Cited by 38 · see citing works
Use Of Medical Care For Chronic Conditions
Decker, S. L., Schappert, S. M., & Sisk, J. E. (2009) · Health Affairs · doi:10.1377/hlthaff.28.1.26 · Cited by 38 · see citing works
Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia
AlMetwazi, M. S., Alwhaibi, M., Balkhi, B. S., Almohaini, H. A., Alturki, H., Alhawassi, T. M., Ata, S. I., Alqahtani, N., Mahmoud, M. A., & Alshammari, T. M. (2018) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2018.12.007 · Cited by 37 · see citing works
Rombopoulos, G., Hatzikou, M., Latsou, D., & Yfantopoulos, J. (2013) · HORMONES · doi:10.14310/horm.2002.1443 · Cited by 34 · see citing works
Wilding, J. P. H., Bailey, C. J., Rigney, U., Blak, B. T., Kok, M. D., & Emmas, C. (2017) · Primary care diabetes · doi:10.1016/j.pcd.2017.04.004 · Cited by 34 · see citing works
Nguyen, Q. C., Whitsel, E. A., Tabor, J. W., Cuthbertson, C. C., Wener, M. H., Potter, A., Halpern, C. T., Killeya‐Jones, L. A., Hussey, J. M., Suchindran, C., et al. (2014) · Annals of Epidemiology · doi:10.1016/j.annepidem.2014.09.010 · Cited by 33 · see citing works
Colorectal Cancer Screening Among Primary Care Patients: Does Risk Affect Screening Behavior?
Felsen, C. B., Piasecki, A. K., Ferrante, J. M., Ohman‐Strickland, P., & Crabtree, B. F. (2011) · Journal of Community Health · doi:10.1007/s10900-010-9348-0 · Cited by 33 · see citing works
Gerber, B. S., Rapacki, L., Castillo, A., Tilton, J., Touchette, D. R., Mihailescu, D., Berbaum, M. L., & Sharp, L. K. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-891 · Cited by 33 · see citing works
Predictors of poor glycaemic control in older patients with type 2 diabetes mellitus
Sazlina, S. G., Mastura, I., Cheong, A. T., Bujang, M. A., Jamaiyah, H., Lee, P. Y., Alwi, S. S., & Chew, B. (2015) · Singapore Medical Journal · doi:10.11622/smedj.2015055 · Cited by 33 · see citing works
Alabousi, M., Abdullah, P., Alter, D. A., Booth, G. L., Hogg, W., Ko, D. T., Manuel, D. G., Farkouh, M. E., Tu, J. V., & Udell, J. A. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.005 · Cited by 31 · see citing works
- Authors
- Ong, K. L., Cheung, B. M. Y., Wong, L. Y. F., Wat, N. M. S., Tan, K. C. B., & Lam, K. S. L.
- Affiliations
- University of Hong Kong (HK)
- Corresponding author
- Cheung, Bernard M.Y.
- Venue
- Annals of Epidemiology
- Publisher
- Elsevier BV
- Published
- 2008-03
- Volume
- 18
- Issue
- 3
- Pages
- 222-229
- ISSN
- 1047-2797 (ISSN-L)
- OpenAlex
- W2029084557
- Cited by
- 232
- References
- 35
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 8 · 2020: 7 · 2019: 6 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 13 · 2014: 21 · 2013: 21 · 2012: 22
- FWCI
- 25.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- diagnosed diabetes, diabetes prevalence, diabetes treatment, glycemic control, blood pressure control, cholesterol management, HbA1c, antidiabetic therapy, diabetes trends, obesity, sex differences, racial differences
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Nutrition Surveys, Regression Analysis, United States, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review